NCT01602341 - Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Dermatitis, Atopic

Interventions

DRUG

AN2728 Topical Ointment, 2% QD

DRUG

AN2728 Topical Ointment, 0.5% QD

DRUG

AN2728 Topical Ointment, 2% BID

DRUG

AN2728 Topical Ointment, 0.5% BID

Trial Locations (17)

Anacor Investigational Site, Kogarah

Anacor Investigational Site, Phillip

Anacor Investigational Site, Fremantle

Anacor Investigational Site, Fremont

Anacor Investigational Site, Miami

Anacor Investigational Site, Lousiville

Anacor Investigational Site, Detroit

Anacor Investigational Site, Albuquerque

Anacor Investigational Site, Stony Brook

Anacor Investigational Site, High Point

Anacor Investigational Site, Portland

Anacor Investigational Site, Knoxville

Anacor Investigational Site, Salt Lake City

Anacor Investigational Site, Norfolk

Anacor Investigational Site, Wooloongabba

Anacor Investigational Site, Box Hill

Anacor Investigational Site, Parkville